Poly(ADP-ribose) polymerase 9 mediates early protection against Mycobacterium tuberculosis infection by regulating

Shyamala Thirunavukkarasu1, Mushtaq Ahmed1, Bruce A Rosa2,3

  • 1Department of Molecular Microbiology.

Insights

Poly(ADP-ribose) polymerase 9 (PARP9) is upregulated in tuberculosis (TB). PARP9 limits type I interferon responses, playing a protective role against Mycobacterium tuberculosis infection.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • ADP ribosyltransferases (PARPs) are crucial for DNA repair and cellular processes.
  • PARP9, a mono-ADP-ribosylating enzyme, shows increased mRNA in human tuberculosis (TB).
  • The role of PARP9 in host immunity against TB remains largely unexplored.

Purpose of the Study:

  • To investigate the role of PARP9 in host immune responses during tuberculosis.
  • To elucidate PARP9's function in DNA damage, cGAS-STING pathway activation, and type I interferon production in TB.

Main Methods:

  • Analysis of PARP9 mRNA expression in human and murine TB models.
  • Phenotypic characterization of Parp9-deficient mice infected with Mycobacterium tuberculosis.
  • Assessment of DNA damage, cGAS and cGAMP levels, type I interferon production, and complement/coagulation pathways.
  • Intervention studies using IFNAR signaling blockade.

Main Results:

  • PARP9 mRNA is upregulated in TB patients and mouse models.
  • Parp9-deficient mice exhibit increased susceptibility to M. tuberculosis infection and TB disease.
  • PARP9 deficiency leads to elevated cGAS and cGAMP expression and heightened type I interferon production.
  • Enhanced susceptibility in Parp9-/- mice is dependent on type I interferon signaling.

Conclusions:

  • PARP9 plays a critical role in modulating DNA damage, cGAS expression, and type I interferon responses during TB.
  • PARP9 acts protectively in TB by limiting type I interferon responses, contrasting its role in viral infections.
  • Targeting PARP9 could offer novel therapeutic strategies for managing tuberculosis.